TrialToxins2023

Clinical Immunogenicity of DaxibotulinumtoxinA for Injection in Glabellar Lines: Pooled Data from the SAKURA Phase 3 Trials.

Conor J Gallagher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.